Evidence mapPaperPMID 40957975Full record

ArticleHormones (Athens, Greece)2025

Effect of melatonin on adipokines, biochemical parameters, clock genes, and lipid metabolism in a rat obesity model.

Héctor Edmundo Álvarez-Loredo, Esther Layseca-Espinosa, Claudia Inés Victoria-Campos, Héctor Hernández-Mendoza, Estefanía Chávez-Prieto, María Judith Rios-Lugo

Abstract read
PubMed Publisher
In one paragraph

Article in Hormones (Athens, Greece), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Héctor Edmundo Álvarez-LoredoPosgrado de Ciencias Biomédicas Básicas, Facultad de Medicina, Universidad Autónoma de San Luis Potosí, Av. Venustiano Carranza 2405, San Luis Potosí, S.L.P, CP 78210, México.
Esther Layseca-EspinosaSección de Medicina Molecular y Traslacional, Centro de Investigación en Ciencias de la Salud y Biomedicina, Universidad Autónoma de San Luis Potosí, Avda. Sierra Leona 550, San Luis Potosí, S.L.P, CP 78210, México.
Claudia Inés Victoria-CamposFacultad de Enfermería y Nutrición, Universidad Autónoma de San Luis Potosí, Avda. Niño Artillero #130, San Luis Potosí, S.L.P, 78210, México.
Héctor Hernández-MendozaInstituto de Investigación de Zonas Desérticas, Universidad Autónoma de San Luis Potosí, Altair 200, San Luis, S.L.P, CP 78377, México.
Estefanía Chávez-PrietoPrograma Multidisciplinario de Posgrado en Ciencias Ambientales, Universidad Autónoma de San Luis Potosí, Zona Universitaria, Av. Manuel Nava 201, San Luis Potosí, S.L.P, CP 78210, México.
María Judith Rios-LugoSección de Medicina Molecular y Traslacional, Centro de Investigación en Ciencias de la Salud y Biomedicina, Universidad Autónoma de San Luis Potosí, Avda. Sierra Leona 550, San Luis Potosí, S.L.P, CP 78210, México. judith.rios@uaslp.mx.ORCID http://orcid.org/0000-0002-2624-5108

Funding

Consejo Nacional de Ciencia y Tecnología PhD scholarship: 465557PRODEP 511-6/18-8377Universidad Autónoma de San Luis Potosí C18-FAI-05-60.60
6 · The paper itself

Abstract

Obesity, characterized by excessive fat accumulation, disrupts metabolism, leading to insulin resistance, hyperglycemia, and dyslipidemia. Circadian rhythm genes such as BMAL1 and CRY1 regulate energy balance, lipid metabolism, and glucose homeostasis, with enzymes, for example, DGAT1 and DGAT2, playing critical roles in triglyceride synthesis. Melatonin, a circadian regulator, influences metabolic processes, including glucose and insulin regulation. This study examined melatonin's therapeutic effects in obese Wistar rats. A total of 48 male rats were fed either a standard diet (C group) or a high-fat diet for 11 weeks to induce obesity. Once the obese group was established, the latter animals were subdivided into two experimental groups, namely, OB (obesity-induced) and OB-M (obesity-induced + melatonin), each under two circadian shifts (9 h and 21 h). During the subsequent 6 weeks, all animals received standard diets plus/minus melatonin supplementation (25 µg/mL in drinking water). The 9 h and 21 h time points were selected to evaluate the effects of circadian rhythm alignment or disruption on metabolic outcomes and melatonin efficacy. Body weight, food intake, and water consumption were recorded every third day. Melatonin supplementation significantly reduced body weight in OB-M group, with no effect observed in the control animals. It also improved glucose, cholesterol, and triglyceride levels compared to diet change alone. Leptin and IL-1β levels decreased with melatonin, suggesting anti-inflammatory and metabolic regulatory effects. Additionally, melatonin influenced circadian gene expression, including BMAL1 and CRY1, and showed correlations with metabolic and inflammatory markers. These findings indicate that melatonin supplementation, when combined with dietary modifications, improves metabolic outcomes and contributes to the restoration of circadian and inflammatory balance in obesity. However, further research is required to elucidate the underlying mechanisms.

Indexed as

AdipokinesLipid MetabolismMelatoninObesityAnimalsARNTL Transcription FactorsCircadian RhythmCLOCK ProteinsCryptochromesDiet, High-FatDisease Models, AnimalMaleRatsRats, WistarAdipokinesARNTL Transcription FactorsCLOCK ProteinsCryptochromesMelatoninATGL)Biochemical parametersCircadian clock genes (BMAL1CRY1)LeptinLipid metabolism (DGAT-1Male wistar ratsMelatonin

Identifiers

PMID40957975

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.